Actively Recruiting
Natural History Study Monitoring Vision Changes in Advanced Rod-Cone Dystrophy Using Standard Care
Led by SparingVision · Updated on 2026-10-08
100
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a natural history study called ECSTASI to monitor how standard of care affects advanced rod-cone dystrophy RCD, an eye disease also known as retinitis pigmentosa. This study does not test any experimental or investigational drugs or treatments. It aims to collect detailed health information to better understand the disease progression and effects of current care. The study gathers data in three parts first, retrospective health information from medical records covering up to the past 10 years second, prospective health information from in-person visits for up to one year and third, prospective health information from medical records for up to one year after enrollment. Participants may choose to take part in all or only some parts of the study. Routine eye exams include tests such as slit lamp exams, dilated fundus exams, best corrected visual acuity, ocular coherence tomography, and microperimetry, along with quality of life questionnaires. During the study, participants undergo scheduled assessments including visual acuity tests and evaluations of visual function at six months and one year. Researchers will measure best-corrected visual acuity and other visual function outcomes to understand how standard care impacts vision over time. Participants will be monitored through both in-person visits and routine medical record reviews, with total follow-up lasting up to one year. The study also looks at potential eligibility for a future clinical trial of SPVN20 NYRVANA.
CONDITIONS
Brief Title
Natural History Study of Advanced RCD
Research Team
S
SparingVision
M
Medical Director
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here